|
|
||||||||
1 Renal Service and Laboratory, Hospital Universitario, Instituto de Investigaciones Biomédicas, Universidad del Zulia, Maracaibo, Zulia 4001-A, Venezuela; 2 Department of Nephrology, Instituto de Cardiología, Mexico City, Tlalpan 14080, Mexico; and 3 Renal Division, Baylor Medical College, Houston, Texas 770030
Immunocompetent cells
infiltrate the kidney in several models of experimental hypertension.
We have previously shown that reduction of this infiltrate results in
prevention of salt-sensitive hypertension induced by short-term
angiotensin II infusion and nitric oxide inhibition (Quiroz Y, Pons H,
Gordon KI, Rincón J, Chávez M, Parra G, Herrera-Acosta J,
Gómez-Garre D, Largo R, Egido J, Johnson RJ, and
Rodríguez-Iturbe B. Am J Physiol Renal Physiol
281: F38-F47, 2001; Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G,
Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, and Johnson
RJ. Kidney Int 59: 2222-2232, 2001). We
therefore studied whether hypertension could be controlled in
genetically hypertensive rats [spontaneously hypertensive rats (SHR)]
by the administration of 20 mg · kg
1 · day
1 of the
immunosuppressive drug mycophenolate mofetil (MMF group; n = 35). Other SHR received vehicle (n = 35), and Wistar-Kyoto rats (n = 20) were used as
controls. MMF or vehicle was given in two separate 4-wk periods,
separated by a 3-wk interval. Systemic hypertension was reduced to
normal levels in both periods of MMF treatment in association with a
reduction in lymphocyte, macrophage, and angiotensin II-positive cells
infiltrating the kidney. Oxidative stress was also reduced by MMF, as
indicated by a reduction in urinary malondialdehyde (MDA), renal MDA
content, and superoxide-positive cells, and was highly correlated with
blood pressure levels. We conclude that the renal immune infiltrate
plays a major role in the hypertension in SHR.
immune cells; spontaneously hypertensive rats; mycophenolate mofetil; oxidative stress
This article has been cited by other articles:
![]() |
Y. Wang and D. H. Wang Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1550 - F1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Elks, N. Mariappan, M. Haque, A. Guggilam, D. S. A. Majid, and J. Francis Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR Am J Physiol Renal Physiol, February 1, 2009; 296(2): F298 - F305. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-D. Liao, X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. A. Cavasin, W. A. Kuziel, P. J. Pagano, and O. A. Carretero Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II-Induced Hypertension Hypertension, August 1, 2008; 52(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Helmut T-cells in angiotensin-II-induced vascular damage Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1107 - 1108. [Full Text] [PDF] |
||||
![]() |
Y. Quiroz, A. Ferrebuz, F. Romero, N. D. Vaziri, and B. Rodriguez-Iturbe Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction Am J Physiol Renal Physiol, February 1, 2008; 294(2): F336 - F344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Graciano, A. Nishiyama, K. Jackson, D. M. Seth, R. M. Ortiz, M. C. Prieto-Carrasquero, H. Kobori, and L. G. Navar Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension Am J Physiol Renal Physiol, January 1, 2008; 294(1): F161 - F169. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tian, R. S. Moore, S. Braddy, R. A. Rose, J.-W. Gu, M. D. Hughson, and R. D. Manning Jr. Interactions between oxidative stress and inflammation in salt-sensitive hypertension Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3388 - H3395. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bravo, Y. Quiroz, A. Ferrebuz, N. D. Vaziri, and B. Rodriguez-Iturbe Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension Am J Physiol Renal Physiol, August 1, 2007; 293(2): F616 - F623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franco, F. Martinez, Y. Quiroz, O. Galicia, R. Bautista, R. J. Johnson, and B. Rodriguez-Iturbe Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R251 - R256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Spurgeon-Pechman, D. L. Donohoe, D. L. Mattson, H. Lund, L. James, and D. P. Basile Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium Am J Physiol Renal Physiol, July 1, 2007; 293(1): F269 - F278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Graciano, C. R. Mouton, M. E. Patterson, D. M. Seth, J. J. Mullins, and K. D. Mitchell Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1858 - F1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Fujihara, D. M. A. C. Malheiros, and R. Zatz Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1810 - F1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yu, R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin Long-Term, High-Dosage Candesartan Suppresses Inflammation and Injury in Chronic Kidney Disease: Nonhemodynamic Renal Protection J. Am. Soc. Nephrol., March 1, 2007; 18(3): 750 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, L. Sepassi, Y. Quiroz, Z. Ni, and N. D. Vaziri Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence J Appl Physiol, January 1, 2007; 102(1): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Gu, N. Tian, M. Shparago, W. Tan, A. P. Bailey, and R. D. Manning Jr. Renal NF-{kappa}B activation and TNF-{alpha} upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1817 - R1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franco, F. Martinez, B. Rodriguez-Iturbe, R. J. Johnson, J. Santamaria, A. Montoya, T. Nepomuceno, R. Bautista, E. Tapia, and J. Herrera-Acosta Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1281 - F1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrera, A. Ferrebuz, E. G. MacGregor, and B. Rodriguez-Iturbe Mycophenolate Mofetil Treatment Improves Hypertension in Patients with Psoriasis and Rheumatoid Arthritis J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S218 - S225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S I van Leuven, J J P Kastelein, M R Hayden, and E S Stroes Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis? Lupus, November 1, 2006; 15(11_suppl): 11 - 17. [Abstract] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe and R. J. Johnson Role of inflammatory cells in the kidney in the induction and maintenance of hypertension Nephrol. Dial. Transplant., February 1, 2006; 21(2): 260 - 263. [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nava, Y. Quiroz, N. Vaziri, and B. Rodriguez-Iturbe Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats Am J Physiol Renal Physiol, March 1, 2003; 284(3): F447 - F454. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zatz, I. L. Noronha, and C. K. Fujihara Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1167 - F1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Alvarez, Y. Quiroz, M. Nava, H. Pons, and B. Rodriguez-Iturbe Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1132 - F1141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |